Corrigendum to Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial [EClinicalMedicine 37 (2021) 100,959]".

Krolewiecki, Alejandro; Lifschitz, Adrián; Moragas, Matías; Travacio, Marina; Valentini, Ricardo; Alonso, Daniel F; Solari, Rubén; Tinelli, Marcelo A et al. · EClinicalMedicine · 2021

Where this comes from

Record sourced from PubMed, PMID 34462733.
Also identified by DOI 10.1016/j.eclinm.2021.101119 and PMC identifier 8387727.
No licence information is recorded for this record.
Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.

Abstract

[This corrects the article DOI: 10.1016/j.eclinm.2021.100959.].

Read the full text

View on PubMed · Publisher (DOI)